- Sputnik International
World
Get the latest news from around the world, live coverage, off-beat stories, features and analysis.

Belarus Will Become the First Country to Receive Russian COVID-19 Vaccine

© Press Service of the Ministry of Health of the Russian Federation / Go to the mediabankIn this handout photo released by Russian Healthcare Ministry, packs with the world's first vaccine against COVID-19 registered in Russia are pictured, in Moscow, Russia
In this handout photo released by Russian Healthcare Ministry, packs with the world's first vaccine against COVID-19 registered in Russia are pictured, in Moscow, Russia - Sputnik International
Subscribe
Russia has become the first country in the world to register a COVID-19 vaccine, which was dubbed Sputnik V. The vaccine was developed by the Gamaleya Institute and is currently undergoing phase III trials.

Belarus will become the first country to receive the Sputnik V Russian vaccine against the coronavirus, the press service for President Lukashenko announced citing his phone conversation with President Putin.

"The two presidents agreed that Belarus citizens will voluntarily take part in phase III trials of the vaccine. Belarus will thus become the first nation to import the Russian vaccine", the press service said.

Russia's Sputnik V Vaccine

A researcher works inside a laboratory of the Gamaleya Scientific Research Institute of Epidemiology and Microbiology where the world's first coronavirus vaccine registered in Russia was developed, in Moscow, Russia. On August 11, Russia announced registering the world's first coronavirus vaccine, dubbed Sputnik V, set to be produced industrially.  - Sputnik International
Russia
Sputnik V: Russia May Start Export of Its COVID-19 Vaccine in Spring 2021, Minister Says
The Sputnik V is the first vaccine against the coronavirus in the world. Developed by the Moscow-based Gamaleya Research Institute and the Russian Defence Ministry, the vaccine was officially registered by the Russian government on 11 August. The phase III trial of the vaccine, involving around 2,000 people, is currently underway.

The Russian Ministry of Health has said that Sputnik V has undergone all the necessary checks and has been proven to be capable of building immunity against the virus.

According to the Russian Direct Investment Fund, it has received applications from more than 20 countries for the purchase of around one billion doses of the vaccine. Russia has contracted the vaccine's production to five countries, with the expected capacity to produce 500 million doses per year.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала